These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10953586)

  • 1. [Value of prostatic specific antigen screening in prostatic cancer].
    Allepuz Losa C; Bosque A; Rioja Sanz LA
    Rev Clin Esp; 2000 Jun; 200(6):323-4. PubMed ID: 10953586
    [No Abstract]   [Full Text] [Related]  

  • 2. [Opportunity for a systematic screening of prostatic cancer by determining prostate specific antigen levels].
    Cuzin B; Maisonneuve H; Thoral F; Charvet-Protat S
    Prog Urol; 2000 Feb; 10(1):124-7. PubMed ID: 10785932
    [No Abstract]   [Full Text] [Related]  

  • 3. Recommendations on use of prostate-specific antigen for prostate cancer screening.
    Garnick MB
    JAMA; 2012 Apr; 307(13):1372; author reply 1372-4. PubMed ID: 22474197
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostate-specific antigen, prostate cancer screening, and the pathologist: what should be our role?
    Jackson BR
    Arch Pathol Lab Med; 2013 Mar; 137(3):308-9. PubMed ID: 22799565
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostate-specific antigen screening for prostate cancer: why so much controversy?
    Labrie F
    Int J Urol; 2013 Nov; 20(11):1148. PubMed ID: 23586435
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening for prostate cancer is not recommended.
    Barendregt JJ
    N Z Med J; 2011 Nov; 124(1346):99-100. PubMed ID: 22143861
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostate specific antigen (PSA)-based screening.
    Suzuki H; Flanigan RC; Okuyama A;
    Int J Urol; 2008 Sep; 15(9):757-62. PubMed ID: 18786202
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostate-specific antigen testing for early diagnosis of prostate cancer: formulation of guidelines.
    Carter HB; Pearson JD
    Urology; 1999 Nov; 54(5):780-6. PubMed ID: 10565733
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostate cancer screening.
    Catalona WJ
    BJU Int; 2004 Nov; 94(7):964-6. PubMed ID: 15541107
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostate-specific antigen (PSA) should drive doing prostate biopsies.
    Loeb S; Catalona WJ
    Urol Oncol; 2012; 30(1):1-2. PubMed ID: 21458316
    [No Abstract]   [Full Text] [Related]  

  • 11. [PSA based screening for prostatic cancer].
    Johansen TE
    Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2612-4. PubMed ID: 19023357
    [No Abstract]   [Full Text] [Related]  

  • 12. Upcoming evidences on prostate-specific antigen-based screening for men at risk of prostate cancer.
    Boscolo-Berto R
    Int J Urol; 2009 Sep; 16(9):711. PubMed ID: 19769655
    [No Abstract]   [Full Text] [Related]  

  • 13. Weighing the benefits and downsides of prostate-specific antigen screening.
    Pignone M
    Arch Intern Med; 2009 Sep; 169(17):1554-6. PubMed ID: 19786672
    [No Abstract]   [Full Text] [Related]  

  • 14. Lowering PSA cutoffs to enhance detection of curable prostate cancer.
    Catalona WJ; Ramos CG; Carvalhal GF; Yan Y
    Urology; 2000 Jun; 55(6):791-5. PubMed ID: 10840078
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnosis of advanced or noncurable prostate cancer can be practically eliminated by prostate-specific antigen.
    Brown M; Feuer E
    Urology; 1997 Feb; 49(2):306-7. PubMed ID: 9037307
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: The free-to-total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general population.
    Elgamal AA; Baert L
    J Urol; 1998 Mar; 159(3):994-5. PubMed ID: 9474213
    [No Abstract]   [Full Text] [Related]  

  • 17. Should I have a PSA screening?
    Hewett ML
    JAAPA; 2012 Jul; 25(7):56. PubMed ID: 22894038
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostate specific antigen and screening for early prostate cancer.
    Davidson P
    N Z Med J; 2001 Apr; 114(1129):150. PubMed ID: 11400919
    [No Abstract]   [Full Text] [Related]  

  • 19. Prostatitis and prostate cancer: implications for prostate cancer screening.
    Kawakami J; Siemens DR; Nickel JC
    Urology; 2004 Dec; 64(6):1075-80. PubMed ID: 15596172
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prostate-specific antigen--the most important cancer marker. Diagnostics and follow up of prostatic cancer have changed].
    Bratt O; Björk T
    Lakartidningen; 2007 Nov 14-20; 104(46):3460-4. PubMed ID: 18072615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.